Scaling a SaaS Selling to Skeptical Scientists with Mike Klein, CEO of Genomenon

About this episode

Dan Balcauski speaks with Mike Klein about scaling Genomenon and selling to scientifically-minded customers.

Dan Balcauski speaks with Mike Klein, CEO of Genomenon, a genomics intelligence company that combines AI, data, and real-world evidence to create a comprehensive knowledge base for precision therapeutics. Mike discusses his journey in scaling Genomenon, the challenges of selling to scientifically-minded customers, and the strategic shift to a freemium model that led to significant adoption. He highlights the complexities of transitioning from a small to a large team, the importance of delegat...

People in this episode

Host: Dan Balcauski

Guest: Mike Klein

Topics covered

• scaling SaaS
• selling to scientists
• freemium model
• team transition
• genomics intelligence

Keywords

• SaaS
• genomics
• AI
• freemium
• sales strategy
• team management
• precision medicine

Mentioned in this episode

Organizations: Genomenon, AI, data, real-world evidence, precision therapeutics

More episodes of SaaS Scaling Secrets

• The Unexpected Ways AI is Shaping SaaS Companies with Tom Car, CEO of Productive · April 7, 2026 · 41 min
• From HBS Dropout to Successful SaaS Exit with Palash Soni, CEO of Goldcast · March 3, 2026 · 40 min
• Tackling AI's Blind Spots with Abhishek Jha, CEO of Elucidata · February 24, 2026 · 36 min
• Conquering the Desperation Mindset in SaaS Pricing with Apurv Bansal, CEO of Zenskar · February 17, 2026 · 39 min
• Balancing a Risk-Reward Model in Real Estate Tech with Alvaro Erize, CEO of CINC · February 3, 2026 · 35 min
• The Truth About AI in the Enterprise with Ed King, CEO of Openprise · January 27, 2026 · 37 min